Torrent Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
TORNTPHARM
Pharmaceuticals
Screen Torrent Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹3869.80
▼
-15.50 (-0.40%)
Share Price BSE
₹3869.45
▼
-15.40 (-0.40%)
Market Cap
₹129,171.09 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
15.36
EPS (TTM)
₹56.47
Dividend Yield
0.16%
Debt to Equity
0.50
52W High
₹3885.30
52W Low
₹2930.30
Operating Margin
31.00%
Profit Margin
17.23%
Revenue (TTM)
₹2,891.00
EBITDA
₹872.00
Net Income
₹498.00
Total Assets
₹14,990.00
Total Equity
₹7,591.00
Torrent Pharmaceuticals Share Price History - Stock Screener Chart
Screen TORNTPHARM historical share price movements with interactive charts. Analyze price trends and patterns.
Torrent Pharmaceuticals Company Profile - Fundamental Screener
Screen Torrent Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TORNTPHARM shares.
Torrent Pharmaceuticals Limited is a leading Indian pharmaceutical company with a global presence. It specializes in cardiovascular, central nervous system, vitamins and nutrients, gastro-intestinal, and anti-diabetes therapies. The company operates through wholly-owned subsidiaries in over 40 countries, with major operations in the US, Germany, and Brazil. Torrent Pharmaceuticals has manufacturing facilities in multiple Indian states and an R&D center in Ahmedabad. Founded in 1959, the company has grown through acquisitions, expansions, and product launches. It has entered various therapeutic segments including dermatology, gynecology, and oncology. Torrent Pharmaceuticals is engaged in research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations both domestically and internationally.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Samir Mehta
ISIN
INE685A01028
Website
https://www.torrentpharma.com
Torrent Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TORNTPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14,990 | 15,061 | 15,012 | 13,100 | 14,075 | 14,010 | 14,121 | 14,243 | 9,702 | 9,058 |
| Current Assets | 5,623 | 5,612 | 5,314 | 5,165 | 5,522 | 4,979 | 5,038 | 5,262 | 4,880 | 4,688 |
| Fixed Assets | 7,947 | 8,138 | 8,122 | 6,423 | 7,065 | 7,533 | 7,748 | 7,855 | 3,688 | 2,859 |
| Liabilities | ||||||||||
| Total Liabilities | 14,990 | 15,061 | 15,012 | 13,100 | 14,075 | 14,010 | 14,121 | 14,243 | 9,702 | 9,058 |
| Current Liabilities | 2,682 | 2,779 | 3,367 | 2,732 | 3,346 | 3,732 | 4,231 | 4,418 | 2,613 | 2,278 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 7,591 | 6,856 | 6,198 | 5,953 | 5,837 | 4,823 | 4,724 | 4,623 | 4,351 | 3,495 |
| Share Capital | 169 | 169 | 169 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
| Reserves & Surplus | 7,422 | 6,687 | 6,029 | 5,868 | 5,753 | 4,739 | 4,640 | 4,538 | 4,266 | 3,410 |
Screen TORNTPHARM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,891 | 3,091 | 3,219 | 2,726 | 2,839 | 2,815 | 2,795 | 2,461 | 2,582 | 2,654 | 2,746 | 2,160 | 2,322 | 2,277 | 2,449 |
| Expenses | 2,019 | 2,146 | 2,232 | 1,862 | 1,955 | 1,950 | 1,895 | 1,764 | 1,800 | 1,835 | 1,863 | 2,055 | 1,635 | 1,612 | 1,767 |
| EBITDA | 872 | 945 | 987 | 864 | 884 | 865 | 900 | 697 | 782 | 819 | 883 | 105 | 687 | 665 | 682 |
| Operating Profit % | 31.00% | 31.00% | 31.00% | 31.00% | 31.00% | 31.00% | 31.00% | 28.00% | 29.00% | 30.00% | 31.00% | 2.00% | 29.00% | 29.00% | 28.00% |
| Depreciation | 201 | 201 | 204 | 203 | 197 | 198 | 199 | 196 | 191 | 201 | 213 | 162 | 155 | 163 | 193 |
| Interest | 56 | 56 | 48 | 80 | 75 | 64 | 57 | 107 | 103 | 91 | 80 | 57 | 55 | 69 | 102 |
| Profit Before Tax | 665 | 738 | 791 | 631 | 656 | 661 | 691 | 433 | 531 | 559 | 631 | -87 | 532 | 463 | 419 |
| Tax | 167 | 190 | 200 | 182 | 199 | 208 | 188 | 146 | 153 | 173 | 188 | 31 | 178 | 151 | 127 |
| Net Profit | 498 | 548 | 591 | 449 | 457 | 453 | 503 | 287 | 378 | 386 | 443 | -118 | 354 | 312 | 292 |
| EPS | 14.71 | 16.19 | 17.54 | 13.27 | 13.51 | 13.37 | 14.88 | 8.48 | 11.18 | 11.39 | 13.10 | -6.97 | 20.90 | 9.22 | 8.63 |
Torrent Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen TORNTPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 2,585 | 3,266 | 2,368 | 1,803 | 2,005 | 1,393 | 1,798 | 894 | 1,009 | 2,742 |
| Investing Activities | -549 | -160 | -2,335 | -196 | -444 | 229 | -246 | -4,677 | -798 | -870 |
| Financing Activities | -2,298 | -2,780 | 77 | -1,781 | -1,651 | -1,549 | -1,314 | 3,417 | -193 | -1,435 |
| Net Cash Flow | -262 | 327 | 110 | -174 | -89 | 73 | 238 | -366 | 18 | 438 |
Screen TORNTPHARM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.31% | 68.31% | 68.31% | 71.25% | 71.25% | 71.25% | 68.31% | 71.25% |
| FII Holding | 16.31% | 16.09% | 15.92% | 14.14% | 14.22% | 14.46% | 16.17% | 0.00% |
| DII Holding | 8.35% | 8.65% | 9.28% | 7.26% | 7.27% | 7.08% | 8.35% | 9.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 4.51% | 4.44% | 4.08% | 4.09% | 3.98% | 4.34% | 4.61% | 4.47% |
| Other Holding | 2.52% | 2.50% | 2.41% | 3.27% | 3.28% | 2.87% | 2.56% | 15.28% |
| Shareholder Count | 86,005 | 81,856 | 78,226 | 71,154 | 74,765 | 79,848 | 85,035 | 63,831 |
Torrent Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen TORNTPHARM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹32.00 | 0.84% |
| 2024-March | ₹28.00 | 0.87% |
| 2023-March | ₹22.00 | 0.85% |
| 2022-March | ₹48.00 | 3.12% |
| 2021-March | ₹35.00 | 2.51% |
| 2020-March | ₹32.00 | 2.51% |
| 2019-March | ₹17.00 | 1.72% |
| 2018-March | ₹14.00 | 1.44% |
| 2017-March | ₹14.00 | 2.24% |
| 2016-March | ₹0.00 | 0.00% |
Torrent Pharmaceuticals Index Membership - Market Screener Classification
Screen TORNTPHARM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Torrent Pharmaceuticals Market Events Screener - Corporate Actions
Screen TORNTPHARM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -0.67% |
| 2025-07-28 | 2025-07-28 | Annual General Meeting | NA | 8.09% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 2.33% |
| 2025-06-20 | 2025-06-20 | Dividend | ₹ 6.00 /share | -4.20% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 2.01% |
| 2025-01-31 | 2025-02-01 | Dividend | ₹ 26.00 /share | -0.21% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -0.25% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -6.75% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 6.63% |
| 2024-06-21 | 2024-06-21 | Dividend | ₹ 6.00 /share | 6.18% |
| 2024-02-12 | 2024-02-12 | Dividend | ₹ 22.00 /share | 5.77% |
| 2023-06-23 | 2023-06-23 | Dividend | ₹ 8.00 /share | 9.19% |
| 2023-02-03 | 2023-02-03 | Dividend | ₹ 14.00 /share | -2.75% |
| 2022-07-08 | 2022-07-11 | Bonus | 1:1 | 1.72% |
| 2022-06-03 | 2022-06-06 | Dividend | ₹ 8.00 /share | 7.26% |
Torrent Pharmaceuticals Competitors Screener - Peer Comparison
Screen TORNTPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,566 | 39.76 | 54,729 | 9.71% | 10,980 | 38.51 |
| Divis Laboratories | 170,630 | 69.39 | 9,712 | 18.67% | 2,191 | 49.65 |
| Torrent Pharmaceuticals | 129,171 | 60.64 | 11,539 | 6.99% | 1,911 | 59.81 |
| Cipla | 121,648 | 22.24 | 28,410 | 7.12% | 5,291 | 47.65 |
| Dr Reddys Laboratories | 105,938 | 18.42 | 33,741 | 16.73% | 5,725 | 51.90 |
| Lupin | 96,485 | 22.16 | 22,910 | 13.74% | 3,306 | 59.99 |
| Zydus Life Science | 91,723 | 18.36 | 23,511 | 18.55% | 4,615 | 38.57 |
| Mankind Pharma | 90,518 | 51.06 | 12,744 | 20.90% | 2,007 | 47.23 |
| Aurobindo Pharma | 70,056 | 20.59 | 32,346 | 9.43% | 3,484 | 53.21 |
| Alkem Laboratories | 66,179 | 27.60 | 13,458 | 3.70% | 2,216 | 42.41 |
Torrent Pharmaceuticals Company Announcements - News Screener
Screen TORNTPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Closure of Trading Window | View |
| 2026-01-02 | Redemption Of Commercial Papers Issued Under ISIN: INE685A14179 | View |
| 2025-12-16 | Redemption Of Commercial Papers Issued Under ISIN INE685A14161 | View |
| 2025-12-12 | Redemption Of Non-Convertible Debentures Issued Under ISIN: INE685A07082 | View |
| 2025-12-10 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-28 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-07 | Partial Redemption Of Commercial Papers Issued Under ISIN INE685A07124 | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-07 | Board Meeting Outcome for Outcome Of Board Meeting Dated 07-Nov-25 | View |
| 2025-11-07 | Results For Quarter And Half Year Ended 30-Sep-25 | View |
| 2025-10-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-27 | Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-21 | Announcement Under Regulation 20 Of SEBI LODR | View |
| 2025-10-07 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-10-07 | Announcement under Regulation 30 (LODR)-Credit Rating | View |